Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries the full behavioral burden. It hints at the return content (similar drugs plus observed vs. IVIVE-predicted clearance) but says nothing about cost, latency, failure modes for invalid SMILES, or whether results are cached — significant gaps for a tool the agent must call blind.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

One sentence, front-loaded with the core action and the returned data. The trailing colon clause ('how IVIVE fared on this kind of structure') adds useful framing about intent rather than waste, though the phrasing is slightly informal.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a small two-parameter tool with no output schema and no annotations, the description conveys the purpose and the gist of the response, which is the minimum viable level. It still omits the `n` parameter's semantics and any indication of result shape or ordering, so it is adequate but not complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, so the description must compensate, and it only implicitly covers the SMILES input. The `n` parameter (count of similar drugs, default 3, max 10) is never mentioned in the description and has no schema description either, leaving its meaning entirely undocumented.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific operation (retrieve most similar reference drugs for a given SMILES) and names the payload (observed and IVIVE-predicted clearance), which is clearly distinct from the computational siblings like calc_clhep or scale_to_human. It is delivered as a noun phrase rather than a verb, and it never explicitly differentiates itself from siblings, so it falls short of a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no when-to-use, when-not-to-use, or alternative guidance. An agent must infer from the name alone that this is the retrieval/comparison step rather than one of the five sibling computation tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.